Published in J Am Acad Dermatol on June 01, 1998
Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci U S A (2002) 2.29
Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells. J Clin Invest (2003) 1.85
Mast cells and the neurofibroma microenvironment. Blood (2010) 1.13
Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression. Annu Rev Pathol (2011) 0.91
Perfusion Imaging of Focal Cortical Dysplasia Using Arterial Spin Labeling: Correlation With Histopathological Vascular Density. J Child Neurol (2013) 0.90
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors. BMC Med (2013) 0.88
Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033. Cancer Biol Ther (2008) 0.88
Differential expression of angiogenic factors in peripheral nerve sheath tumors. Clin Exp Metastasis (2008) 0.79
Cutaneous Angioneurofibroma: A New Histopathological Variant of Neurofibroma. Dermatopathology (Basel) (2014) 0.75
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A (1994) 6.48
Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation (1999) 3.53
A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci (1996) 3.49
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Rapid death after admission to palliative care. Intern Med J (2012) 3.25
Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst (1996) 3.23
Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A (1997) 2.88
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci U S A (2001) 2.81
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology (1996) 2.41
A factual, not arbitrary, basis for choice of resection margins in melanoma. Arch Dermatol (1996) 2.12
Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice. J Natl Cancer Inst (2001) 2.10
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel. Arch Dermatol (1997) 2.02
Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res (1997) 1.97
A quantitative model of invasive Pseudomonas infection in burn injury. J Burn Care Rehabil (1994) 1.91
Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase. Nature (2000) 1.84
Curcumin is an in vivo inhibitor of angiogenesis. Mol Med (1998) 1.81
Zebrafish angiogenesis: a new model for drug screening. Angiogenesis (1999) 1.74
Spitz tumors in children: a grading system for risk stratification. Arch Dermatol (1999) 1.71
A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol (1994) 1.64
Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol (1998) 1.60
Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. J Am Acad Dermatol (1989) 1.59
Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res (2001) 1.55
2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci U S A (1994) 1.43
Leukemic vasculitis: a feature of leukemia cutis in some patients. Am J Clin Pathol (1997) 1.37
Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer (1995) 1.33
Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity. Am J Pathol (1999) 1.33
Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat Med (1997) 1.31
Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. Am J Pathol (1992) 1.29
Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int J Cancer (1993) 1.27
Troponin I is present in human cartilage and inhibits angiogenesis. Proc Natl Acad Sci U S A (1999) 1.23
Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J Clin Invest (1998) 1.22
Sunlamp use and the risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA. Int J Epidemiol (1998) 1.21
Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol (1984) 1.14
Desmoplastic melanoma. Histopathology (1992) 1.14
Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis. Genes Immun (2010) 1.13
Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol (1998) 1.11
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res (1996) 1.10
Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas. Arch Dermatol (1993) 1.08
Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol (1996) 1.07
Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases. Am J Surg Pathol (1998) 1.07
Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J Am Acad Dermatol (1982) 1.07
Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma. J Clin Epidemiol (1999) 1.04
Increased thickness of pregnancy-associated melanoma. Br J Dermatol (1995) 1.02
Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol (2000) 1.01
Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. J Natl Cancer Inst (2001) 1.00
Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol (1996) 0.99
Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin. J Invest Dermatol (1999) 0.99
Histologic regression in malignant melanoma: an interobserver concordance study. J Cutan Pathol (1993) 0.97
The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice. J Am Acad Dermatol (1999) 0.97
Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol (2006) 0.96
Association of the CCR5 gene with juvenile idiopathic arthritis. Genes Immun (2010) 0.95
Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. Int J Cancer (1996) 0.95
Multiple primary cutaneous melanomas. Cancer (1992) 0.95
Validation of a melanoma prognostic model. Arch Dermatol (1998) 0.95
Physical examination and arteriography in patients with penetrating zone II neck wounds. Arch Surg (1994) 0.93
Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol (1993) 0.93
The Spitz tumor 50 years later: revisiting a landmark contribution and unresolved controversy. J Am Acad Dermatol (1999) 0.92
Small cell sweat gland carcinoma in childhood. Am J Surg Pathol (1998) 0.92
Primary malignant melanoma of the external auditory canal: a case report with presentation as an aural polyp. Am J Otol (1992) 0.91
Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin. Lab Invest (1994) 0.90
Histologic spectrum of cutaneous involvement in patients with myelogenous leukemia including the neutrophilic dermatoses. Int J Dermatol (1995) 0.90
Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol (1997) 0.90
Interactions of 2-methoxyestradiol, an endogenous mammalian metabolite, with unpolymerized tubulin and with tubulin polymers. Biochemistry (1996) 0.89
Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor. Aust N Z J Ophthalmol (1996) 0.89
Dipole localization of human induced focal afterdischarge seizure in simultaneous magnetoencephalography and electrocorticography. Brain Topogr (2001) 0.88
Basement membrane alterations in oral lichen planus. J Invest Dermatol (1978) 0.88
Immunoenhancing agents and experimental leukoplakia and carcinoma of the hamster buccal pouch. Prog Exp Tumor Res (1979) 0.88
Malignant melanoma in situ: functional considerations of cancer. Hum Pathol (1990) 0.88
The one year incidence of postoperative myocardial infarction in an orthopedic population. HSS J (2007) 0.88
Evaluation of factors associated with skin self-examination. Cancer Epidemiol Biomarkers Prev (1999) 0.87
Common acquired melanocytic nevi, dysplastic melanocytic nevi and malignant melanomas: an image analysis cytometric study. J Cutan Pathol (1993) 0.86
C16 laminin peptide increases angiotropic extravascular migration of human melanoma cells in a shell-less chick chorioallantoic membrane assay. Br J Dermatol (2007) 0.86
Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas. Eur J Cancer (2003) 0.86
Spontaneous regression of cutaneous tumors. Adv Dermatol (1993) 0.86
Ultrastructural and immunohistochemical studies of the periendothelial matrix in human melanoma: evidence for an amorphous matrix containing laminin. J Cutan Pathol (1999) 0.86
Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators. Circulation (1995) 0.85
The importance of elastic fibres in skin lymphatics. Br J Dermatol (1983) 0.85
Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol (1998) 0.85
Characteristics of cultivated adult human nevocellular nevus cells. J Invest Dermatol (1986) 0.84
Is magnetic resonance imaging the 'reference standard' for cardiac functional assessment? Factors influencing measurement of left ventricular mass and volumes. Clin Res Cardiol (2007) 0.84
Malignant blue nevus. Case report and literature review. J Am Acad Dermatol (1988) 0.84
Tumor microvessels in melanoma express the beta-2 chain of laminin. Implications for melanoma metastasis. J Cutan Pathol (1999) 0.84
A systematic investigation of confirmed autoimmune loci in early-onset psoriasis reveals an association with IL2/IL21. Br J Dermatol (2011) 0.84
Epidemiology of cutaneous melanoma. An update. Dermatol Clin (1991) 0.84
Melanoma and extravascular migratory metastasis. J Cutan Pathol (2000) 0.84
Pagetoid Spitz nevus. Intraepidermal Spitz tumor with prominent pagetoid spread. Am J Surg Pathol (1995) 0.83
Tumour vascularity is not a prognostic factor for cutaneous melanoma. Lancet (1994) 0.83
Angiogenesis and regressing cutaneous malignant melanoma. Lancet (1992) 0.83
Dysplastic nevi in association with multiple primary melanoma. Cancer Res (1988) 0.83
Hypotensive epidural anaesthesia in patients with preoperative renal dysfunction undergoing total hip replacement. Br J Anaesth (2005) 0.83
Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis. Melanoma Res (2003) 0.82
Workplace toxic exposures involving adolescents aged 14 to 19 years: one poison center's experience. Arch Pediatr Adolesc Med (2000) 0.82
Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas. J Immunol (1996) 0.82
Inter-clinician agreement on the recognition of clinical pigmentary characteristics of patients with cutaneous malignant melanoma. Studies of melanocytic nevi, VI. Br J Cancer (1991) 0.82
Prediction of histologic melanocytic dysplasia from clinical observation. J Am Acad Dermatol (1993) 0.81
Expression of basic fibroblast growth factor in desmoplastic melanoma. J Cutan Pathol (1996) 0.81